Literature DB >> 2783972

Serum neopterin changes in HIV-infected subjects: indicator of significant pathology, CD4 T cell changes, and the development of AIDS.

R N Melmed1, J M Taylor, R Detels, M Bozorgmehri, J L Fahey.   

Abstract

Serum neopterin is a metabolite of dihydroneopterin triphosphate, which is produced from GTP during immune activation. A study was undertaken in homosexual male subjects followed at 6 month intervals for 3 or more years to determine the value of serum neopterin changes induced by HIV infection. The significance of serum neopterin levels in evaluating prognosis of HIV-infected individuals was also assessed. Serum neopterin was found to be a useful indicator of the presence of HIV infection. Stratification of 29 HIV seroconverters showed a strong inverse correlation between the serum neopterin rise and the blood CD4 T cell fall in the first year following HIV infection. Thus, a small increase in neopterin (less than 5 nmol/L) at the time of HIV seroconversion was associated with minimal CD4 T cell reduction and a large increase (greater than 12 nmol/L) was associated with a much greater CD4 T cell fall. Neopterin levels were markedly different (lower) in individuals with little or no CD4 T cell fall when compared with those with moderate or marked rates of T cell fall. This relationship between serum neopterin and the CD4 T cell level was further confirmed by an evaluation of both parameters in a group of 799 seropositive homosexual men. In this analysis, serum neopterin was shown to have a significant predictive value for the development of AIDS within 3 years. Furthermore, when serum neopterin and CD4 T cell measurements were considered together, the prognostic value of the combination was significantly greater than either alone.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2783972

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr (1988)        ISSN: 0894-9255


  15 in total

1.  Highly active antiretroviral therapy (HAART) and circulating markers of immune activation: specific effect of HAART on neopterin.

Authors:  N Amirayan-Chevillard; H Tissot-Dupont; Y Obadia; H Gallais; J L Mege; C Capo
Journal:  Clin Diagn Lab Immunol       Date:  2000-09

2.  Urinary neopterin concentrations and T-cell subset data in HIV-1 infection.

Authors:  G Reibnegger; D Fuchs; J J Goedert; A Hausen; A Krämer; E R Werner; G Werner-Felmayer; M P Dierich; H Wachter
Journal:  Klin Wochenschr       Date:  1990-01-04

Review 3.  Cytokines, plasma immune activation markers, and clinically relevant surrogate markers in human immunodeficiency virus infection.

Authors:  J L Fahey
Journal:  Clin Diagn Lab Immunol       Date:  1998-09

4.  Early levels of CD4, neopterin, and beta 2-microglobulin indicate future disease progression.

Authors:  M Shi; J M Taylor; J L Fahey; D R Hoover; A Muñoz; L A Kingsley
Journal:  J Clin Immunol       Date:  1997-01       Impact factor: 8.317

Review 5.  Neopterin and beta 2-microglobulin as prognostic indices in human immunodeficiency virus type 1 infection.

Authors:  D Fuchs; A Krämer; G Reibnegger; E R Werner; M P Dierich; J J Goedert; H Wachter
Journal:  Infection       Date:  1991       Impact factor: 3.553

6.  Relation of impaired lymphocyte proliferative function to other major human immunodeficiency virus type 1-induced immunological changes.

Authors:  H Z Bass; J L Fahey; P Nishanian; R Detels; W Cumberland; M Kemeny; S Plaeger
Journal:  Clin Diagn Lab Immunol       Date:  1997-01

7.  Prevalence of antibodies to human herpesviruses and hepatitis B virus in patients at different stages of human immunodeficiency virus (HIV) infection.

Authors:  R Enzensberger; W Braun; C July; E B Helm; H W Doerr
Journal:  Infection       Date:  1991 May-Jun       Impact factor: 3.553

8.  Levels of cytokines and immune activation markers in plasma in human immunodeficiency virus infection: quality control procedures.

Authors:  N Aziz; P Nishanian; J L Fahey
Journal:  Clin Diagn Lab Immunol       Date:  1998-11

9.  Variables that affect assays for plasma cytokines and soluble activation markers.

Authors:  N Aziz; P Nishanian; R Mitsuyasu; R Detels; J L Fahey
Journal:  Clin Diagn Lab Immunol       Date:  1999-01

10.  Raised levels of tumour necrosis factor-alpha and neopterin, but not interferon-alpha, in serum of HIV-1-infected patients from Ethiopia.

Authors:  S Ayehunie; A Sonnerborg; T Yemane-Berhan; D W Zewdie; S Britton; O Strannegard
Journal:  Clin Exp Immunol       Date:  1993-01       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.